Press Releases
Quaker Chemical Announces Second Quarter 2015 Results
Foreign currency translation continued to have a significant impact on the Company's reported and non-GAAP results. Specifically, net sales for the second quarter of 2015 decreased by 7% due to foreign currency translation while earnings were also negatively impacted by
Mr. Barry added, "We continue to pursue our key strategic initiatives and acquisitions. Today's acquisition of Verkol in
Second Quarter of 2015 Summary
Net sales for the second quarter of 2015 were
Gross profit for the second quarter of 2015 increased
The increase in selling, general and administrative expenses ("SG&A") for the second quarter of 2015 of
Interest expense was slightly higher in the second quarter of 2015 compared to the second quarter of 2014. The Company had higher average borrowings outstanding in the current quarter to fund the Company's recent acquisition activity.
Interest income was
The Company's effective tax rates for the second quarters of 2015 and 2014 were 27.1% and 30.6%, respectively. The primary contributor to the decrease in the current quarter's effective tax rate was lower changes to reserves for uncertain tax positions in the second quarter of 2015.
Equity in net income of associated companies ("equity income") decreased
The
Changes in foreign exchange rates negatively impacted the second quarter of 2015 net income by
Year-to-Date 2015 Summary
Net sales for the first six months of 2015 were
Gross profit for the first six months of 2015 increased
The increase in SG&A for the first six months of 2015 of
Other expense was
Interest expense was
Interest income was
The Company's effective tax rates for the first six months of 2015 and 2014 were 28.8% and 32.5%, respectively. The primary contributors to the decrease in the current year's effective tax rate were lower changes in reserves related to uncertain tax positions in the first six months of 2015 and certain one-time items that increased the first six months of 2014's effective tax rate. We currently estimate the full year 2015 effective tax rate will approximate 29%.
Equity income decreased
The
Changes in foreign exchange rates, excluding the currency conversion impacts of the Venezuelan Bolivar Fuerte, noted above, negatively impacted the first six months of 2015 net income by
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of
Non-GAAP Measures
Included in this public release are non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP (unaudited) financial measures:
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders |
$ 1.13 |
$ 1.16 |
$ 1.90 |
$ 2.13 |
|||||||
Equity loss (income) in a captive insurance company per diluted share |
0.01 |
(0.09) |
(0.05) |
(0.15) |
|||||||
U.K. pension plan amendment per diluted share |
— |
— |
— |
0.05 |
|||||||
U.S. customer bankruptcy per diluted share |
0.01 |
— |
0.01 |
— |
|||||||
Cost streamlining initiatives per diluted share |
— |
0.02 |
0.01 |
0.02 |
|||||||
Currency conversion impact of the Venezuelan Bolivar Fuerte per diluted share |
— |
0.02 |
0.21 |
0.02 |
|||||||
Non-GAAP earnings per diluted share |
$ 1.15 |
$ 1.11 |
$ 2.08 |
$ 2.07 |
|||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||
Net income attributable to Quaker Chemical Corporation |
$ 15,038 |
$ 15,427 |
$ 25,416 |
$ 28,157 |
|||||||
Depreciation and amortization |
4,666 |
3,824 |
9,364 |
7,712 |
|||||||
Interest expense |
607 |
581 |
1,194 |
1,106 |
|||||||
Taxes on income before equity in net income of associated companies |
5,724 |
6,538 |
11,083 |
13,084 |
|||||||
Equity loss (income) in a captive insurance company |
100 |
(1,225) |
(695) |
(2,071) |
|||||||
U.K. pension plan amendment |
— |
— |
— |
902 |
|||||||
U.S. customer bankruptcy |
111 |
— |
111 |
— |
|||||||
Cost streamlining initiatives |
— |
348 |
173 |
348 |
|||||||
Currency conversion impact of the Venezuelan Bolivar Fuerte |
— |
321 |
2,806 |
321 |
|||||||
Adjusted EBITDA |
$ 26,246 |
$ 25,814 |
$ 49,452 |
$ 49,559 |
|||||||
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
|||||||
Condensed Consolidated Statements of Income |
|||||||
(Dollars in thousands, except per share data) |
|||||||
(Unaudited) |
|||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||
2015 |
2014 |
2015 |
2014 |
||||
Net sales |
$ 183,726 |
$ 191,286 |
$ 365,056 |
$ 372,960 |
|||
Cost of goods sold |
113,109 |
123,070 |
228,111 |
239,630 |
|||
Gross profit |
70,617 |
68,216 |
136,945 |
133,330 |
|||
% |
38.4% |
35.7% |
37.5% |
35.7% |
|||
Selling, general and administrative expenses |
49,172 |
47,271 |
97,636 |
93,012 |
|||
Operating income |
21,445 |
20,945 |
39,309 |
40,318 |
|||
% |
11.7% |
10.9% |
10.8% |
10.8% |
|||
Other (expense) income, net |
(88) |
117 |
(282) |
(356) |
|||
Interest expense |
(607) |
(581) |
(1,194) |
(1,106) |
|||
Interest income |
375 |
895 |
695 |
1,348 |
|||
Income before taxes and equity in net income of associated companies |
21,125 |
21,376 |
38,528 |
40,204 |
|||
Taxes on income before equity in net income of associated companies |
5,724 |
6,538 |
11,083 |
13,084 |
|||
Income before equity in net income of associated companies |
15,401 |
14,838 |
27,445 |
27,120 |
|||
Equity in net income (loss) of associated companies |
11 |
1,104 |
(1,426) |
2,131 |
|||
Net income |
15,412 |
15,942 |
26,019 |
29,251 |
|||
Less: Net income attributable to noncontrolling interest |
374 |
515 |
603 |
1,094 |
|||
Net income attributable to Quaker Chemical Corporation |
$ 15,038 |
$ 15,427 |
$ 25,416 |
$ 28,157 |
|||
% |
8.2% |
8.1% |
7.0% |
7.5% |
|||
Per share data: |
|||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 1.13 |
$ 1.17 |
$ 1.91 |
$ 2.13 |
|||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 1.13 |
$ 1.16 |
$ 1.90 |
$ 2.13 |
|||
Quaker Chemical Corporation |
||||
Condensed Consolidated Balance Sheets |
||||
(Dollars in thousands, except par value and share amounts) |
||||
(Unaudited) |
||||
June 30, |
December 31, |
|||
2015 |
2014 |
|||
ASSETS |
||||
Current assets |
||||
Cash and cash equivalents |
$ 65,784 |
$ 64,731 |
||
Accounts receivable, net |
187,415 |
189,484 |
||
Inventories, net |
77,041 |
77,708 |
||
Prepaid expenses and other current assets |
20,614 |
19,595 |
||
Total current assets |
350,854 |
351,518 |
||
Property, plant and equipment, net |
81,370 |
85,763 |
||
Goodwill |
76,017 |
77,933 |
||
Other intangible assets, net |
66,034 |
70,408 |
||
Investments in associated companies |
20,078 |
21,751 |
||
Deferred income taxes |
20,740 |
24,411 |
||
Other assets |
32,971 |
33,742 |
||
Total assets |
$ 648,064 |
$ 665,526 |
||
LIABILITIES AND EQUITY |
||||
Current liabilities |
||||
Short-term borrowings and current portion of long-term debt |
$ 397 |
$ 403 |
||
Accounts and other payables |
74,762 |
78,977 |
||
Accrued compensation |
13,784 |
19,853 |
||
Other current liabilities |
24,997 |
25,668 |
||
Total current liabilities |
113,940 |
124,901 |
||
Long-term debt |
61,694 |
75,328 |
||
Deferred income taxes |
7,454 |
8,584 |
||
Other non-current liabilities |
86,450 |
91,578 |
||
Total liabilities |
269,538 |
300,391 |
||
Equity |
||||
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2015 - 13,336,918 shares; 2014 - 13,300,891 shares |
13,337 |
13,301 |
||
Capital in excess of par value |
103,082 |
99,056 |
||
Retained earnings |
315,060 |
299,524 |
||
Accumulated other comprehensive loss |
(60,771) |
(54,406) |
||
Total Quaker shareholders' equity |
370,708 |
357,475 |
||
Noncontrolling interest |
7,818 |
7,660 |
||
Total equity |
378,526 |
365,135 |
||
Total liabilities and equity |
$ 648,064 |
$ 665,526 |
||
Quaker Chemical Corporation |
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
(Unaudited) |
|||
Six Months Ended June 30, |
|||
2015 |
2014 |
||
Cash flows from operating activities |
|||
Net income |
$ 26,019 |
$ 29,251 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||
Depreciation |
6,117 |
6,084 |
|
Amortization |
3,247 |
1,628 |
|
Equity in undistributed earnings of associated companies, net of dividends |
1,487 |
(1,931) |
|
Deferred compensation and other, net |
1,325 |
3,340 |
|
Stock-based compensation |
3,169 |
2,732 |
|
Gain on disposal of property, plant and equipment and other assets |
(69) |
(97) |
|
Insurance settlements realized |
(301) |
(980) |
|
Pension and other postretirement benefits |
1,019 |
(926) |
|
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
|||
Accounts receivable |
(2,344) |
(20,563) |
|
Inventories |
(1,993) |
(7,568) |
|
Prepaid expenses and other current assets |
(4,057) |
1,157 |
|
Accounts payable and accrued liabilities |
(6,301) |
(3,873) |
|
Net cash provided by operating activities |
27,318 |
8,254 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(4,277) |
(5,521) |
|
Payments related to acquisitions, net of cash acquired |
528 |
- |
|
Proceeds from disposition of assets |
102 |
128 |
|
Insurance settlement interest earned |
20 |
23 |
|
Change in restricted cash, net |
281 |
957 |
|
Net cash used in investing activities |
(3,346) |
(4,413) |
|
Cash flows from financing activities |
|||
Proceeds from long-term debt |
- |
7,500 |
|
Repayment of long-term debt |
(12,699) |
(248) |
|
Dividends paid |
(7,991) |
(6,607) |
|
Stock options exercised, other |
534 |
(33) |
|
Payments for repurchase of common stock |
(1,630) |
- |
|
Excess tax benefit related to stock option exercises |
378 |
267 |
|
Purchase of a noncontrolling interest in an affiliate |
- |
(7,532) |
|
Payment of acquisition-related earnout liability |
- |
(4,709) |
|
Distributions to noncontrolling affiliate shareholders |
- |
(657) |
|
Net cash used in financing activities |
(21,408) |
(12,019) |
|
Effect of exchange rate changes on cash |
(1,511) |
(82) |
|
Net increase (decrease) in cash and cash equivalents |
1,053 |
(8,260) |
|
Cash and cash equivalents at the beginning of the period |
64,731 |
68,492 |
|
Cash and cash equivalents at the end of the period |
$ 65,784 |
$ 60,232 |
|
Logo - http://photos.prnewswire.com/prnh/20120910/PH70044LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quaker-chemical-announces-second-quarter-2015-results-300121490.html
SOURCE
Margaret M. Loebl, Vice President, Chief Financial Officer and Treasurer, loeblm@quakerchem.com, T. 610.832.4160